{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T16:09:47Z","timestamp":1769357387223,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.antiviral.2015.11.012","type":"journal-article","created":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T14:13:40Z","timestamp":1449929620000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans"],"prefix":"10.1016","volume":"126","author":[{"given":"Hong","family":"Vu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Shulenin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen","family":"Grolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Audet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihua","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Kobinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Unfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly L.","family":"Warfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Javad","family":"Aman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick W.","family":"Holtsberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.11.012_bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1084\/jem.20011500","article-title":"Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses","volume":"195","author":"Bavari","year":"2002","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.antiviral.2015.11.012_bib2","doi-asserted-by":"crossref","first-page":"e96360","DOI":"10.1371\/journal.pone.0096360","article-title":"Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus","volume":"9","author":"Becquart","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2015.11.012_bib3","doi-asserted-by":"crossref","first-page":"e9126","DOI":"10.1371\/journal.pone.0009126","article-title":"High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon","volume":"5","author":"Becquart","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2015.11.012_bib4","first-page":"1","article-title":"Classification, structure, and replication of filoviruses","volume":"235","author":"Feldmann","year":"1999","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2015.11.012_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3527(08)60733-2","article-title":"Marburg and Ebola viruses","volume":"47","author":"Feldmann","year":"1996","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2015.11.012_bib6","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1126\/science.1259657","article-title":"Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak","volume":"345","author":"Gire","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.11.012_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2005.02.015","article-title":"Analysis of Ebola virus and VLP release using an immunocapture assay","volume":"127","author":"Kallstrom","year":"2005","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.antiviral.2015.11.012_bib8","doi-asserted-by":"crossref","first-page":"15951","DOI":"10.1074\/jbc.M601796200","article-title":"Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor","volume":"281","author":"Kuhn","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.11.012_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2015.11.012_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vaccine.2007.10.064","article-title":"Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines","volume":"26","author":"Miura","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2015.11.012_bib11","doi-asserted-by":"crossref","first-page":"17182","DOI":"10.1073\/pnas.1414164111","article-title":"Structures of protective antibodies reveal sites of vulnerability on Ebola virus","volume":"111","author":"Murin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2015.11.012_bib12","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1128\/JVI.76.10.4855-4865.2002","article-title":"Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP","volume":"76","author":"Noda","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2015.11.012_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrmicro2129","article-title":"Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule","volume":"7","author":"Sullivan","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2015.11.012_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0928-8244(03)00273-6","article-title":"Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein(1)","volume":"40","author":"Swenson","year":"2004","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.antiviral.2015.11.012_bib15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/jcp.31.6.507","article-title":"Enzyme immunoassays with special reference to ELISA techniques","volume":"31","author":"Voller","year":"1978","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.antiviral.2015.11.012_bib16","doi-asserted-by":"crossref","first-page":"15889","DOI":"10.1073\/pnas.2237038100","article-title":"Ebola virus-like particles protect from lethal Ebola virus infection","volume":"100","author":"Warfield","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2015.11.012_bib17","doi-asserted-by":"crossref","first-page":"e0118881","DOI":"10.1371\/journal.pone.0118881","article-title":"Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles","volume":"10","author":"Warfield","year":"2015","journal-title":"PLoS One"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421530036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421530036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T02:53:52Z","timestamp":1537152832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421530036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":17,"alternative-id":["S016635421530036X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.11.012","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}